850524 | CHEMS
cholesteryl hemisuccinate
CHEMS
cholesteryl hemisuccinate
CAS Registry Number is a Registered Trademark of the American Chemical Society
5-Cholesten-3β-ol
3-hemisuccinate
CHS
Cruz N, Pinho JO, Soveral G, Ascensão L, Matela N, Reis C, Gaspar MM. A Novel Hybrid Nanosystem Integrating Cytotoxic and Magnetic Properties as a Tool to Potentiate Melanoma Therapy. Nanomaterials (Basel). 2020 Apr 6;10(4):693. doi: 10.3390/nano10040693. PMID: 32268611; PMCID: PMC7221742.
PubMed ID: 32268611Wang YQ, Ji MY, Wang C. Endoplasmic reticulum-targeted glutathione and pH dual responsive vitamin lipid nanovesicles for tocopheryl DM1 delivery and cancer therapy. Int J Pharm. 2020 May 30;582:119331. doi: 10.1016/j.ijpharm.2020.119331. Epub 2020 Apr 11. PMID: 32289484.
PubMed ID: 32289484Yao Y , Feng L , Wang Z , Chen H , Tan N . Programmed delivery of cyclopeptide RA-V and antisense oligonucleotides for combination therapy on hypoxic tumors and for therapeutic self-monitoring. Biomater Sci. 2019 Dec 17;8(1):256-265. doi: 10.1039/c9bm00905a. PMID: 31687671.
PubMed ID: 31687671Samaddar S, Mazur J, Boehm D, Thompson DH. Development And In Vitro Characterization Of Bladder Tumor Cell Targeted Lipid-Coated Polyplex For Dual Delivery Of Plasmids And Small Molecules. Int J Nanomedicine. 2019 Dec 4;14:9547-9561. doi: 10.2147/IJN.S225172. PMID: 31824150; PMCID: PMC6900316.
PubMed ID: 31824150Li Y, Zhai Y, Liu W, Zhang K, Liu J, Shi J, Zhang Z. Ultrasmall nanostructured drug based pH-sensitive liposome for effective treatment of drug-resistant tumor. J Nanobiotechnology. 2019 Nov 29;17(1):117. doi: 10.1186/s12951-019-0550-7. PMID: 31783863; PMCID: PMC6884872.
PubMed ID: 31783863Ramesh A, Brouillard A, Kumar S, Nandi D, Kulkarni A. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy. Biomaterials. 2020 Jan;227:119559. doi: 10.1016/j.biomaterials.2019.119559. Epub 2019 Oct 19.
PubMed ID: 31670078Ramesh A, Brouillard A, Kumar S, Nandi D, Kulkarni A. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy. Biomaterials. 2020 Jan;227:119559. doi: 10.1016/j.biomaterials.2019.119559. Epub 2019 Oct 19.
PubMed ID: 31670078Roth MS, Westcott DJ, Iwai M, Niyogi KK. Hexokinase is necessary for glucose-mediated photosynthesis repression and lipid accumulation in a green alga. Commun Biol. 2019 Sep 19;2:347. doi: 10.1038/s42003-019-0577-1. eCollection 2019.
PubMed ID: 31552300Mozumder S, Bej A, Srinivasan K, Mukherjee S, Sengupta J. Comprehensive structural modeling and preparation of human 5-HT2A G-protein coupled receptor in functionally active form. Biopolymers. 2019 Aug 30:e23329. doi: 10.1002/bip.23329. [Epub ahead of print]
PubMed ID: 31469412Kanamala M, Palmer BD, Jamieson SM, Wilson WR, Wu Z. Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery. Nanomedicine (Lond). 2019 Aug;14(15):1971-1989. doi: 10.2217/nnm-2018-0510. Epub 2019 Jul 29.
PubMed ID: 31355712Dolstra CC, Rinker T, Sankhagowit S, Deng S, Ting C, Dang AT, Kuhl TL, Sasaki DY. Mechanism of Acid-Triggered Cargo Release from Lipid Bilayer-Coated Mesoporous Silica Particles. Langmuir. 2019 Aug 13;35(32):10276-10285. doi: 10.1021/acs.langmuir.9b01087. Epub 2019 Jul 22.
PubMed ID: 31280569Huang X, Chau Y. Investigating impacts of surface charge on intraocular distribution of intravitreal lipid nanoparticles. Exp Eye Res. 2019 Jun 22;186:107711. doi: 10.1016/j.exer.2019.107711. [Epub ahead of print]
PubMed ID: 31238078Kim H, Nobeyama T, Honda S, Yasuda K, Morone N, Murakami T. Membrane fusogenic high-density lipoprotein nanoparticles. Biochim Biophys Acta Biomembr. 2019 Jun 14. pii: S0005-2736(19)30139-7. doi: 10.1016/j.bbamem.2019.06.007. [Epub ahead of print]
PubMed ID: 31207206Ramesh, A., Natarajan, S.K., Nandi, D. et al. Dual Inhibitors-Loaded Nanotherapeutics that Target Kinase Signaling Pathways Synergize with Immune Checkpoint Inhibitor. Cel. Mol. Bioeng. (2019). doi: 10.1007/s12195-01900576-1
Pinho JO, Amaral JD, Castro RE, Rodrigues CM, Casini A, Soveral G, Gaspar MM. Copper complex nanoformulations featuring highly promising therapeutic potential in murine melanoma models. Nanomedicine (Lond). 2019 Apr;14(7):835-850. doi: 10.2217/nnm-2018-0388. Epub 2019 Mar 15.
PubMed ID: 30875274Thompson AA, Liu JJ, Chun E, Wacker D, Wu H, Cherezov V, Stevens RC. GPCR stabilization using the bicelle-like architecture of mixed sterol-detergent micelles. Methods. 2011 Dec;55(4):310-7. doi: 10.1016/j.ymeth.2011.10.011. Epub 2011 Oct 21.
PubMed ID: 22041719Bicelles can be integrated into standard crystallization protocols, and in contrast to micelles, bicelles maintain the protein in a more native bilayer environment allowing proteins to be captured in a more biologically relevant orientation. Reference/Protocol
- Certificate of Analysis (Lot No. 850524P-1G-A-014 and 5703PQA014)
- Certificate of Analysis (Lot No. 850524P-5G-A-014 and 5703PRA014)
- Certificate of Analysis (Lot No. 850524P-1G-B-014 and 5703PQB014)
- Certificate of Analysis (Lot No. 850524P-5G-B-014 and 5703PRB014)
- Certificate of Analysis (Lot No. 850524P-1G-C-014 and 5703PQC014)
- Certificate of Analysis (Lot No. 850524P-1G-D-014 and 5703PQD014)
- Certificate of Analysis (Lot No. 850524P-5G-C-014 and 5703PRC014)
- Certificate of Analysis (Lot No. 850524P-1G-E-014 and 5703PQE014)
- Certificate of Analysis (Lot No. 850524P-1G-F-014 and 5703PQF014)
- Certificate of Analysis (Lot No. 850524P-5G-D-014 and 5703PRD014)
- Certificate of Analysis (Lot No. 850524P-5G-E-014 and 5703PRE014)
- Certificate of Analysis (Lot No. 850524P-5G-A-015 and 5703PRA015)
- Certificate of Analysis (Lot No. 850524P-1G-G-014 and 5703PQG014)
- Certificate of Analysis (Lot No. 850524P-5G-B-015 and 5703PRB015)
- Certificate of Analysis (Lot No. 850524P-1G-A-015 and 5703PQA015)
- Certificate of Analysis (Lot No. 850524P-1G-B-015 and 5703PQB015)
- Certificate of Analysis (Lot No. 850524P-5G-E-015 and 5703PRE015)
- Certificate of Analysis (Lot No. 850524P-1G-C-015 and 5703PQC015)
- Certificate of Analysis (Lot No. 850524P-1G-D-015 and 5703PQD015)
- Certificate of Analysis (Lot No. 850524P-5G-G-015 and 5703PRG015)
- Certificate of Analysis (Lot No. 850524P-1G-E-015 and 5703PQE015)
- Certificate of Analysis (Lot No. 850524P-5G-F-015 and 5703PRF015)
- Certificate of Analysis (Lot No. 850524P-1G-F-015 and 5703PQF015)
- Certificate of Analysis (Lot No. 850524P-5G-H-015 and 5703PRH015)
- Certificate of Analysis (Lot No. 850524P-1G-G-015 and 5703PQG015)